Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, December 18, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Pharma
Agilent Receives Multiple Innovation Awards
Life Sciences Times
-
December 14, 2020
0
Real Estate
Blackstone Real Estate Acquires Premier Lab Office Portfolio from Brookfield Fund
Life Sciences Times
-
December 14, 2020
0
Pharma
908 Devices Announces Launch of Initial Public Offering
Life Sciences Times
-
December 14, 2020
0
Biotech
EdiGene Appointments Bo Zhang as Head of US Subsidiary and Kehua Fan Head of Business Development
Life Sciences Times
-
December 14, 2020
0
Real Estate
Colliers International’s Recent Sale Assignment Demonstrates Momentum of Life Science Market
Life Sciences Times
-
December 14, 2020
0
Medtech
Zebra Medical Vision Secures a 7th FDA Clearance for Its Patented Breakthrough in Orthopedic Surgery Planning
Life Sciences Times
-
December 14, 2020
0
Biotech
Gilead Sciences to Acquire MYR GmbH
Life Sciences Times
-
December 12, 2020
0
Public Health
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
Life Sciences Times
-
December 12, 2020
0
Pharma
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
Life Sciences Times
-
December 12, 2020
0
Medtech
Quidel Corporation CEO Douglas Bryant Named Executive of the Year in MedTech Dive Awards
Life Sciences Times
-
December 12, 2020
0
1
...
568
569
570
...
572
Page 569 of 572
Most Popular
VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
December 16, 2024
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
December 16, 2024
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
December 12, 2024
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
December 12, 2024
Load more
Recent Comments
Recent Comments